149 related articles for article (PubMed ID: 36195933)
1. Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response.
Liu L; Huang Y; Fu Y; Rao J; Zeng F; Ji M; Xu X; Zhu J; Du W; Liu Z
Infect Agent Cancer; 2022 Oct; 17(1):52. PubMed ID: 36195933
[TBL] [Abstract][Full Text] [Related]
2. GP73 facilitates hepatitis B virus replication by repressing the NF-κB signaling pathway.
Liu L; Zhu J; Yang J; Li X; Yuan J; Wu J; Liu Z
J Med Virol; 2020 Dec; 92(12):3327-3335. PubMed ID: 32077512
[TBL] [Abstract][Full Text] [Related]
3. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
[TBL] [Abstract][Full Text] [Related]
4. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
Zhang X; Zhu C; Wang T; Jiang H; Ren Y; Zhang Q; Wu K; Liu F; Liu Y; Wu J
PLoS Pathog; 2017 Apr; 13(4):e1006321. PubMed ID: 28394926
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis.
Sai W; Wang L; Zheng W; Yang J; Pan L; Cai Y; Qiu L; Zhang H; Wu W; Yao D
Hepat Mon; 2015 Dec; 15(12):e32918. PubMed ID: 26977166
[TBL] [Abstract][Full Text] [Related]
6. PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1.
Huang F; Guo J; Zhao N; Hou M; Gai X; Yang S; Cai P; Wang Y; Ma Q; Zhao Q; Li L; Yang H; Jing Y; Jin D; Hu Z; Zha X; Wang H; Mao Y; Liu F; Zhang H
J Transl Med; 2024 Mar; 22(1):254. PubMed ID: 38459588
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells.
Kondo Y; Kimura O; Tanaka Y; Ninomiya M; Iwata T; Kogure T; Inoue J; Sugiyama M; Morosawa T; Fujisaka Y; Shimosegawa T
J Virol; 2015 Jul; 89(14):7016-27. PubMed ID: 25926643
[TBL] [Abstract][Full Text] [Related]
8. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus upregulates GP73 expression by activating the HIF-2α signaling pathway.
Yang SL; Zeng C; Fang X; He QJ; Liu LP; Bao SY; Pan X; Xiong ZF
Oncol Lett; 2018 Apr; 15(4):5264-5270. PubMed ID: 29552166
[TBL] [Abstract][Full Text] [Related]
10. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
[TBL] [Abstract][Full Text] [Related]
11. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.
Cao Z; Li Z; Wang Y; Liu Y; Mo R; Ren P; Chen L; Lu J; Li H; Zhuang Y; Liu Y; Wang X; Zhao G; Tang W; Xiang X; Wang H; Cai W; Liu L; Zhu C; Bao S; Xie Q
J Viral Hepat; 2017 Nov; 24 Suppl 1():57-65. PubMed ID: 29082644
[TBL] [Abstract][Full Text] [Related]
13. Golgi protein 73, hepatocellular carcinoma and other types of cancers.
Wang Y; Wan YY
Liver Res; 2020 Dec; 4(4):161-167. PubMed ID: 33343966
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
15. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
16. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
[TBL] [Abstract][Full Text] [Related]
17. GP73, a new marker for diagnosing HBV-ACLF in population with chronic HBV infections.
Wei H; Zhang J; Li H; Ren H; Hao X; Huang Y
Diagn Microbiol Infect Dis; 2014 May; 79(1):19-24. PubMed ID: 24560809
[TBL] [Abstract][Full Text] [Related]
18. Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.
Xu Z; Liu L; Pan X; Wei K; Wei M; Liu L; Yang H; Liu Q
Medicine (Baltimore); 2015 Mar; 94(12):e659. PubMed ID: 25816035
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Promotes Hepatocellular Carcinoma Progression Synergistically With Hepatic Stellate Cells
Deng W; Chen F; Zhou Z; Huang Y; Lin J; Zhang F; Xiao G; Liu C; Liu C; Xu L
Front Mol Biosci; 2021; 8():745990. PubMed ID: 34805271
[No Abstract] [Full Text] [Related]
20. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection.
Qiao Y; Chen J; Li X; Wei H; Xiao F; Chang L; Zhang R; Hao X; Wei H
Clin Biochem; 2014 Nov; 47(16-17):216-22. PubMed ID: 25168922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
